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Microbial translocation is a cause of systemic immune activation in 
chronic HIV infection
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Chronic activation of the immune system is a hallmark of
progressive HIV infection and better predicts disease out-
come than plasma viral load, yet its etiology remains
obscure. Here, we show that circulating microbial prod-
ucts, likely derived from the gastrointestinal tract, are a
primary cause of HIV-related systemic immune activation.
Circulating lipopolysaccharide, an indicator of microbial
translocation, is significantly increased in chronically
HIV-infected individuals and SIV-infected rhesus
macaques. We show that monocytes are chronically stim-
ulated in vivo by increased lipopolysaccharide, which also
correlates with measures of innate and adaptive immune
activation. Effective antiretroviral therapy appears to
reduce microbial translocation. Furthermore, in non-
pathogenic SIV infection of sooty mangabeys, microbial
translocation does not seem to occur. These data establish
a mechanism for chronic immune activation in the con-
text of a compromised gastrointestinal mucosal surface
and provide novel directions for therapeutic interventions
that modify the consequences of acute HIV infection.
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